US Republican Senator Tim Scott pulls out of presidential campaign
The Republicans' only black senator has been trailing far behind Donald Trump in polls.
2023-11-13 14:45
Dubai Restarts Privatizations After a Year With Taxi IPO
Dubai kickstarted its privatization program after a one-year hiatus with the planned initial public offering of its taxi
2023-11-13 14:26
General Atlantic Agrees to Buy Majority Stake in Joe & the Juice
General Atlantic has reached a deal to acquire control of Joe & the Juice, the high street chain
2023-11-13 14:26
Moody’s Tail Risk Has Italy on Edge Before Critical Rating Call
A possible downgrade of Italy to junk this week would be hugely symbolic, potentially consequential — and very
2023-11-13 13:27
Renault Casts Fledgling EV Business as Europe’s Answer to Tesla
After clearing up record losses and a toxic partnership, Renault SA Chief Executive Officer Luca de Meo is
2023-11-13 13:25
Israel Latest: US Strikes Iran-Linked Targets in Eastern Syria
The US conducted airstrikes in eastern Syria on targets linked to Iran, Defense Secretary Lloyd Austin said, while
2023-11-13 13:17
Euro-Zone Inflation Seen Slowing More Quickly in Latest Survey
Euro-area inflation will sink below the 2% target in early 2025 — sooner than the European Central Bank
2023-11-13 13:15
Senator Tim Scott Drops Out of Republican Presidential Race
South Carolina Senator Tim Scott is ending his presidential campaign, a long-shot bid to offer an alternative to
2023-11-13 12:19
Korea’s Kosdaq Index Set to Erase All Gains From Shorting Ban
The boost to South Korean stocks from the nation’s move to ban short-selling has quickly faded, with an
2023-11-13 11:48
DP World: Australia ports remain closed after cyber-attack
Operations at DP World sites in Melbourne, Sydney, Brisbane and Perth have been suspended since Friday.
2023-11-13 11:46
K-Pop Giant Hybe Buys Its First Latin Music Company
Hybe Co., the South Korean music company behind pop groups BTS and NewJeans, has acquired the music division
2023-11-13 11:16
One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year
A single dose of an experimental drug from Eli Lilly & Co. cut by 94% a risk factor
2023-11-13 09:27